Últimas noticias sobre SEALSQ (NASDAQ:LAES) Bolsa

SEALSQ

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.

Box,Headquarters,In,Redwood,City,,California,,Usa,-,June,8,

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

BROG

CETX

CODI

GLXY

IFRX

IMNN

JFBR

JOBY

LAES

LVWR

NEHC

OKTA

PMAX

SGBX

SONN

WORX

Descubre qué acciones destacan en el premercado de EE. UU., desde subidas explosivas como Box hasta caídas por anuncios clave.

Las acciones de Box se disparan un 12%; Aquí están 20 acciones que se mueven en el premercado

ARQT

ATPC

BDTX

DRCT

GCTK

ITCI

LDTC

QBTS

QMMM

RGTI

RIME

SAGE

STAI

TRAW

VMAR

Sage Therapeutics sube 34% tras oferta de Biogen. Conoce los mayores ganadores y perdedores del premercado de EE.UU.

Las acciones de Sage Therapeutics (SAGE) se disparan un 34%; 20 acciones que se mueven en premercado

AMPG

AREB

BHAT

BWMN

CALM

DATS

DRIO

EONR

GRFX

HOTH

JBDI

SANA

SLDB

SVMH

XTIA

Movimientos destacados del premercado: Cal-Maine Foods sube un 3,8%, Sana Biotechnology lidera con un 220,6%.

Las acciones de Cal-Maine Foods suben un 4%; Aquí están 20 acciones que se mueven en el premercado

SEALSQ Corp

Needham analyst Laura Martin reiterates Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) with a Buy and maintains $84 price target.

Price Target

Reiteration

Analyst Ratings

Needham Reiterates Buy on Trade Desk, Maintains $84 Price Target

LULU: -23% &#x7C; <a href="https://www.benzinga.com//node/45803006">Lululemon Athletica shares are trading lower after the company cut its FY25 GAAP EPS guidance below estimates.</a>
&nbsp;
AVGO: -5% &#x7C; <a href="https://www.benzinga.com//node/45802886">Broadcom shares are trading lower following Q2 reported financial results.</a>
&nbsp;
TSLA: 6% &#x7C; <a href="https://www.benzinga.com//node/45807968">Trump Signals Truce With Elon Musk After Online Feud: 'It's Going Very Well, Never Done Better'</a>

AVGO

LULU

TSLA

Market-Moving News for June 6th

D. Boral Capital analyst Jason Kolbert maintains Artelo Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARTL#NASDAQ">ARTL</a>) with a Buy and maintains $6 price target.

ARTL

D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $6 Price Target

Needham analyst Ryan Koontz reiterates Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) with a Buy and maintains $90 price target.

CIEN

Needham Reiterates Buy on Ciena, Maintains $90 Price Target

Phosphate and Potash Operations Outlook
Phosphate sales volumes for the second quarter of 2025 are expected to be 1.5-1.6 million tonnes, revised down from 1.7-1.9 million tonnes. 2025 full year production volume is now expected to be 7.0-7.3 million tonnes, revised down from 7.2-7.6 million tonnes.

Guidance

UPDATE: Mosaic Company Revises Outlook: Sees Q2 Phosphate Sales Volume At 1.5–1.6M Tonnes, Down From 1.7M–1.9M Prior; FY25 Output Trimmed To 7.0M–7.3M Tonnes Vs 7.2M-7.6M Tonnes Prior

RYVYL Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVYL#NASDAQ">RVYL</a>) ("RYVYL" or the "Company"), a leading innovator of payment transaction solutions leveraging electronic payment technology, announced the securityholder of its remaining 8% Senior Convertible Note ("Note"), has converted the entire outstanding principal balance of $4.0 million and accrued interest of $136,000 into 7.1 million shares of common stock.

RVYL

RYVYL's Securityholder Converts Final $4M Senior Note, Including $136K Interest, Into 7.1M Shares

Earnings

MANU

Manchester United Q3 2025 Adj. EPS $(0.04) May Not Be Comparable To $(0.33) Estimate, Sales $207.26M Beat $202.47M Estimate

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Constellation Brands Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>)</h3>
<ul class="wp-block-list">
<li>On June 2, Constellation Brands announced delivery of notices of redemption for 4.75% senior notes due 2025 and 5.00% senior notes due 2026. The company's stock fell around 9% over the past month and has a 52-week low of $160.46.</li>
<li>RSI Value: 26.8</li>
<li>STZ Price Action: Shares of Constellation fell 3.6% to close at $170.60 on Thursday.</li>
<li>Edge Stock Ratings: 18.63 Momentum score with Value at 14.10. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/STZ"><img loading="lazy" decoding="async" width="441" height="183" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071110/image-87.png" alt="" class="wp-image-941078" style="width:325px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071110/image-87.png 441w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071110/image-87-300x124.png 300w" sizes="(max-width: 441px) 100vw, 441px" /></a></figure>
<h3 class="wp-block-heading">Coca-Cola Consolidated Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COKE#NASDAQ">COKE</a>)</h3>
<ul class="wp-block-list">
<li>On May 15, Coca-Cola Consolidated announced a $90 million investment in Columbus facility. &#8220;The investment we&#8217;ve made here in Columbus is evidence of our focus on growth in Columbus,&#8221; said Sam Meiner, VP, Mid-West Market Unit at Coca-Cola Consolidated. &#8220;This commitment to our teammates and production capabilities is a long-term dedication to improving how we serve the world&#8217;s best brands and flavors to our communities and the people of Ohio.&#8221; The company's stock fell around 10% over the past month and <a href="https://www.benzinga.com/quote/COKE">has a 52-week low</a> of $96.60.</li>
<li>RSI Value: 25.8</li>
<li>COKE Price Action: Shares of Coca-Cola Consolidated fell 1.4% to close at $106.17 on Thursday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0606">COKE stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0606"><img loading="lazy" decoding="async" width="927" height="851" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071215/image-88.png" alt="" class="wp-image-941079" style="width:652px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071215/image-88.png 927w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071215/image-88-300x275.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071215/image-88-768x705.png 768w" sizes="(max-width: 927px) 100vw, 927px" /></a></figure>
<h3 class="wp-block-heading">Diageo PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>)</h3>
<ul class="wp-block-list">
<li>On May 19, Diageo reported a third-quarter fiscal 2025 trading update that showed steady growth in organic net sales and progress on its operational transformation efforts. The maker of Smirnoff and Guinness posted $4.4 billion in net sales for the quarter ended March 31, marking a 2.9% increase year-over-year. Organic net sales rose 5.9%, driven by stronger pricing and shipment volumes. The company's stock fell around 8% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/DEO">low of $100.72.</a></li>
<li>RSI Value: 29</li>
<li>DEO Ltd Price Action: Shares of Diageo fell 5.1% to close at $105.20 on Thursday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0606">DEO shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0606"><img loading="lazy" decoding="async" width="862" height="832" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071542/image-89.png" alt="" class="wp-image-941080" style="width:661px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071542/image-89.png 862w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071542/image-89-300x290.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06071542/image-89-768x741.png 768w" sizes="(max-width: 862px) 100vw, 862px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a>
Read This Next:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45789751/jim-cramer-likes-dominion-energy-but-isnt-a-fan-of-this-real-estate-stock">Jim Cramer Likes Dominion Energy, But Isn&#8217;t &#8216;A Fan&#8217; Of This Real Estate Stock</a> </li>
</ul>
Photo via Shutterstock

Long Ideas

COKE

Top 3 Risk Off Stocks That Could Blast Off This Month

Needham analyst Mike Cikos reiterates Cellebrite DI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLBT#NASDAQ">CLBT</a>) with a Buy and maintains $24 price target.

CLBT

Needham Reiterates Buy on Cellebrite DI, Maintains $24 Price Target

Fury Gold Mines Limited (NYSE:<a href="https://www.benzinga.com/stock/FURY#NYSE">FURY</a>) ("Fury" or the "Company") announces that the proposed private placement offering announced June 5, 2025 has been increased from C$2,500,000 to C$3,080,000. Fury now intends to privately place with a small group of accredited and institutional investors in Canada a total of 4,000,000 flow-through common shares (the "Shares") of the Company, at a price of C$0.77 per Share for total gross proceeds of C$3,080,000 (the "Offering"). This offering figure could increase by up to approximately 15.4% if a strategic investor elects to exercise its pre-emptive participation rights disclosed in a <a href="https://www.globenewswire.com/Tracker?data=HQaYc8Cgq_iu2dRsUPGUu4P8s3eHB2eh9WbW-ZLoEWjXoCqjvRLyTfYk3hp6kqzAmBb84_tbBVoR_n5MFK0Ixq9Z6MdXWXYjmhnHy6AtbvrgY_wLYJ1ItwqiqvhkOwikomCI1oUBmQMZQ53iXZrkOtyfCPzsDPY_b__Zik8XVFI=">May 27, 2025 news release</a>.
The Offering is expected to close on or about June 19, 2025 (the "Closing Date"), subject to execution of subscription agreements and customary closing conditions, including receipt of all necessary approvals, including the approval of the Toronto Stock Exchange ("TSX") and the NYSE American LLC. Other previously announced terms and conditions remain the same.

FURY

Fury Gold Mines Increases Proposed Private Placement Offering From C$2.50M To C$3.08M

G-III Apparel Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIII#NASDAQ">GIII</a>) is looking for Q2 Adj EPS of $0.02-$0.12 vs $0.48 analyst estimate. Q2 Revenue expected to be more than $570.00M vs $621.00M Est

GIII

G-III Apparel Group Sees Q2 EPS $0.02-$0.12; Q2  Revenue Expected To Be Approximately $570.00M vs $621.00M Est

PRPH

ProPhase Labs Forms Clinical Science Advisory Board To Support Clinical Adoption And Commercialization Of Breakthrough BE-Smart Molecular Test For Esophageal Disease

D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCEL#NASDAQ">RCEL</a>) with a Buy and maintains $19 price target.

RCEL

D. Boral Capital Maintains Buy on AVITA Medical, Maintains $19 Price Target

Sandisk Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDK#NASDAQ">SNDK</a>) (the "Company" or "Sandisk") announced today the pricing of a secondary public offering (the "Offering") of 18,534,581 shares of its common stock (the "SNDK Shares") currently owned by Western Digital Corporation, the Company's former parent ("WDC"). The size of the offering reflects an increase from the 17,000,000 shares of common stock originally proposed to be sold. The SNDK Shares will be offered at a public offering price of $38.50 per share. Sandisk is not selling any shares of common stock and will not receive any proceeds from the sale of the SNDK Shares in the Offering or from the debt-for-equity exchange.

SNDK

Sandisk Announces Pricing For Expanded Secondary Offering; WDC to Sell 18.5M Shares, Priced at $38.50/Shr

Needham analyst Tom Nikic maintains Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) with a Buy and lowers the price target from $366 to $317.

Needham Maintains Buy on Lululemon Athletica, Lowers Price Target to $317

Manchester United (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MANU#NYSE">MANU</a>) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.33) by 87.88 percent. This is a 87.1 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $202.03 million which missed the analyst consensus estimate of $202.47 million by 0.22 percent. This is a 16.53 percent increase over sales of $173.37 million the same period last year.

Earnings Beats

Earnings Misses

Manchester United Q3 Adj. EPS $(0.04) Beats $(0.33) Estimate, Sales $202.03M Miss $202.47M Estimate

G-III Apparel Anticipates Unmitigated Cost Of Tariffs On Goods Imported Into The United States Will Result In Additional Expense Of $135M, Which Will Primarily Be Weighted To The Second Half Of The Year

<a href="https://www.globenewswire.com/Tracker?data=n4VAc1wDtm5Gx7yfSA9G9Bdm2S_5VbQKkJDwPg3B940asDE5ZukU5_AOibtKC3kemI6XkVzqXtwCjRwSJvfq1cpQeANnCCU7jEhQPnli8rQ=">BioCryst Pharmaceuticals, Inc. </a>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCRX#NASDAQ">BCRX</a>) today announced that, following a positive recommendation from the Zorginstituut Nederland, ORLADEYO&#xAE; (berotralstat) has been approved for the routine prevention of hereditary angioedema (HAE) attacks in patients aged 12 years and older. This reimbursement approval in the Netherlands marks national reimbursement for ORLADEYO across all major European countries, providing HAE patients with access to the first oral, once-daily preventive therapy.

BCRX

Netherlands Approves BioCryst Pharma's ORLADEYO For Hereditary Angioedema Prevention, Expanding National Access Across Europe

G-III Apparel Has Withdrawn Its Net Income, Non-GAAP Net Income And Adjusted EBITDA Guidance For FY26 Due To Uncertainty Around Tariffs And Related Macroeconomic Conditions

Strategy&#x2122; (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) today announced the pricing of its initial public offering on June 5, 2025 of 11,764,700 shares of 10.00% Series A Perpetual Stride Preferred Stock (the "STRD Stock"), at a public offering price of $85.00 per share. The issuance and sale of the STRD Stock are scheduled to settle on June 10, 2025, subject to customary closing conditions.
Strategy estimates that the net proceeds to it from the offering will be approximately $979.7 million, after deducting the underwriting discounts and commissions and Strategy's estimated offering expenses. Strategy intends to use the net proceeds from the offering for general corporate purposes, including the acquisition of bitcoin and for working capital.

IPOs

MSTR

Strategy Prices IPO Of 11.8M Shares Of 10.00% Series A Perpetual Stride Preferred Stock At Public Offering Price Of $85.00/Shr

Press Releases

SEALSQ Invests in Wecan Token to Advance Post-Quantum Digital Identity and Strengthen Blockchain Security, following a Strategic Partnership with SOLANA

SEALSQ CORP Announces Signature of Share Purchase Agreement to Acquire 100% of IC'ALPS

SEALSQ Corp, a member of the WISeKey Group, Signs a Share Purchase Agreement to Acquire 100% of IC'ALPS

SEALSQ Chosen by Hager for Matter-Compliant Device Attestation in Next-Gen Smart Home Products

WISeKey to Present at Maxim Tech Conference "Discover the Innovations Reshaping Tomorrow" on June 3 at 8:30am ET

WISeKey's WISe.ART 3.0, One of the World's First and Largest Web3 Marketplaces for Digital Art, Twins, NFTs, and Crypto Collectibles will be Presenting FABEN's MLove at NFC Lisbon on June 5 on the Alpha Stage at 4:30

SEALSQ and WISeSat Next Satellite Launch Scheduled for Mid-June From California to Advance Quantum-Safe Space Communications

WISeKey's WISeSat Confirms Next Satellite Launch Scheduled for Mid-June from California to Advance Quantum-Safe Space Communications

WISeKey International Holding Ltd Announces Adjournment of 2025 Annual General Meeting

Small Cap

Opinion

Encryption May Soon Be Worthless. The Race to Replace It Is Creating a New Investment Boom

CHKP

CSE:SCPE

PANW

SCPCF

WKEY

WSKEF

Ambarella

Alpha and Omega Semiconductor Limited - Common Shares

Alpha & Omega

Blaize Holdings

CEVA

Canadian Solar

GSI Technology

Himax Technologies, Inc. - American depositary shares, each of which represents two ordinary shares.

Himax Techs

Intchains Group Limited - American Depositary Shares

Intchains Gr

ChipMOS TECHNOLOGIES INC. - American Depositary Shares

ChipMOS TECHNOLOGIES

indie Semiconductor, Inc. - Class A Common Stock

Indie Semiconductor

JinkoSolar Holding Company Limited American Depositary Shares (each representing 4 Common Shares)

JinkoSolar Holding Co

Kopin

Everspin Technologies, Inc. - Common Stock

Everspin Technologies

Magnachip Semiconductor Corporation Common Stock

MagnaChip Semiconductor

MaxLinear

Nano Labs

Navitas Semiconductor Corporation - Common Stock

Navitas Semiconductor

Penguin Solutions, Inc. - Ordinary Shares

Penguin Solutions

QuickLogic

SkyWater Technology

Sequans Communications S.A. American Depositary Shares (each representing ten (10) Ordinary Shares)

Comments

SEALSQ

Noticias

Últimas noticias sobre SEALSQ (NASDAQ:LAES) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL